We assessed the capacity of four probiotic bacteria (Lactobacillus acidophilus, Lactobacillus reuteri, Lactobacillus casei GG, and Bifidobacterium animalis) to colonize, infect, stimulate immune responses in, and affect the growth and survival of congenitally immunodeficient gnotobiotic beige-athymic (bg/bg-nu/nu) and beige-euthymic (bg/bg-nu/؉) mice. The bacteria colonized and persisted, in pure culture, in the alimentary tracts of both mouse strains for the entire study period (12 weeks). Although all adult and neonatal beige-euthymic mice survived probiotic colonization, some infant mortality occurred in beige-athymic pups born to mothers colonized with pure cultures of L. reuteri or L. casei GG. The probiotic bacteria manifested different capacities to adhere to epithelial surfaces, disseminate to internal organs, affect the body weight of adult mice and the growth of neonatal mice, and stimulate immune responses. Although the probiotic species were innocuous for adults, these results suggest that caution and further studies to assess the safety of probiotic bacteria for immunodeficient hosts, especially neonates, are required.
Probiotics are microorganisms that are ingested to promote beneficial effects on health. An important benefit of probiotics is their capacity to curtail or prevent infectious diseases. For example, studies in humans have shown that probiotic consumption can diminish diarrhea during rotavirus infections (23) and reduce the recurrence of vaginal candidiasis (7) . Animal experiments suggest that oral probiotics can interfere with colonization and infection by Escherichia coli (4) , Candida albicans (6, 21, 25) , and Shigella sonnei (15) . Thus, probiotics have great potential as adjuncts or alternatives to conventional antibiotic therapy for infectious diseases.
A serious consideration related to the use of probiotics is whether they are opportunistic pathogens, especially in immunodeficient hosts. Probiotics appear to be innocuous for immunocompetent hosts (1); however, bacteria closely related to probiotic species have been associated with infections in patients. For example, Streptococcus spp. and Lactobacillus spp. have been isolated from patients with heart valve replacements who have endocarditis (16) . Infections by lactic acid bacteria are usually attributed to endogenous flora and not to strains used in foods and probiotic preparations (14) . The possible risk of opportunistic infection supports the need for research on the safety of probiotics in immunodeficient hosts.
In this study, we evaluated the capacity of probiotic bacteria to colonize and infect congenitally immunodeficient germfree (GF) beige-athymic (bg/bg-nu/nu) and beige-euthymic (bg/bgnu/ϩ) mice.
MATERIALS AND METHODS
Bacteria. We used bacterial cultures that are readily available for use as human probiotics. Lactobacillus acidophilus, Lactobacillus reuteri, and Bifidobacterium infantis were obtained from BioGaia Biologics, Inc., Raleigh, N.C. The B. infantis strain has subsequently been determined, by ribosomal DNA typing, to be B. animalis (12a) . Lactobacillus casei GG was obtained from Valio, Ltd., Helsinki, Finland. All bacteria were incubated overnight at 37°C in deManRogosa-Sharpe (MRS) medium (Difco, Detroit, Mich.) or on plates of MRS medium with 1.5% agar in anaerobe jars (GasPak; BBL, Cockeysville, Md.) containing anaerobic generators (AnaeroPack System; Carr-Scarborough Microbiologics, Decatur, Ga.). The probiotics were identified and characterized with the API 50CH biochemical identification system (BioMéreiux Vitek, St. Louis, Mo.), and fatty acid analysis was performed by gas-liquid chromatography (Microbial ID, Inc., Newark, Del.).
Mice. NIH bg/bg-nu/nu and bg/bg-nu/ϩ mice were obtained from GF breeding stocks maintained at the University of Wisconsin Gnotobiote Laboratory, Madison (http://www.biostat.wisc.edu/gnotolab/gnotolab.html). GF male bg/bg-nu/nu and female bg/bg-nu/ϩ mice were housed in sterile flexible-film isolators and were mated to obtain litters of approximately equal numbers of nude and heterozygous mice. A pure culture of each probiotic species was introduced into an isolator containing GF mice. The mice were inoculated by swabbing their oral cavity and anal area with a culture that contained approximately 10 8 viable bacteria per ml. Additional GF mice and newborn mice were colonized by being exposed to feces, feed, and bedding from monoassociated mice. Colonization of the mice was monitored by enumeration of viable bacteria in the feces of gnotobiotic mice. Dilutions of feces were inoculated onto MRS agar plates and incubated at 37°C in anaerobe jars. All the mice were fed autoclaved food and water ad libitum.
Survival and growth of immunodeficient mice colonized with probiotics. Survival of mice born to probiotic-colonized mothers was assessed at 4 and 8 weeks of age. Adult GF mice were colonized with a pure culture of probiotic bacteria, and their body weights and survival were recorded at 4 and 8 weeks after bacterial colonization. Differences in the survival of GF mice and probioticcolonized mice were evaluated by Kaplan-Meier survival analysis with log rank probability statistics.
Body weights were measured on a Sartorius balance (Brinkman Instruments, Westbury, N.Y.). The body weights of adult mice and the growth rates of newborn mice between 4, 8, and 12 weeks of age were compared with those of GF control mice.
Gastrointestinal tract colonization. Colonization of the gastrointestinal tracts of GF mice with probiotic bacteria was assayed by counting colonies of viable bacteria (CFU) recovered from the contents of the stomachs, small intestines, cecua, and colons of mice that had been sacrificed. The contents were washed out of the organs with sterile water and serially diluted, and 50-l aliquots were inoculated onto MRS agar plates. The plates were dried briefly and incubated at 37°C overnight in anaerobic jars. A 1-ml aliquot of each 5-ml suspension of intestinal contents was dried overnight in a tared aluminum weighing dish at 80°C. The dried dishes were cooled to room temperature and weighed. The number of viable bacteria is expressed as log 10 CFU per gram (dry weight) of contents. The pH of the gastrointestinal tract contents was measured with a pH meter and a glass combination electrode (Fisher Scientific Co., Chicago, Ill.).
The spleen, liver, and kidney were aseptically excised, and a portion of each (half a spleen, half a kidney, and a liver lobe) was combined and homogenized in a glass tissue grinder with 5 ml of sterile distilled water, serially diluted, and cultured on anaerobic MRS agar plates overnight at 37°C to detect and quantify the systemic dissemination of the probiotic bacteria. The number of viable bacteria in the internal organs was recorded as CFU per gram (dry weight) of tissue.
Histological evaluations. The alimentary tracts and internal organs of mice that had been sacrificed were fixed in 10% formaldehyde in phosphate-buffered saline (PBS) (pH 7.4). The fixed tissues were dissected, embedded in paraffin, and sectioned (5-m sections) onto slides for staining with hematoxylin and eosin and Gram stains. Tissue sections of the alimentary tract and the major internal organs were evaluated by a pathologist for evidence of infection and inflammation. Photomicrographs were produced with a Nikon Optiphot microscope (Nikon Inc., Melville, N.Y.) equipped with a Nikon DX-100M automatic camera and a Sony charge-coupled device camera attached to a Targa frame grabber (Truevision, Inc., Indianapolis, Ind.) with Image Pro Plus imaging software (Media Cybernetics, Silver Spring, Md.).
Immune response to probiotics. Immunoglobulin G (IgG), IgA, and IgM concentrations in serum were determined by commercial radial immunodiffusion assays as specified by the manufacturer (The Binding Site, Inc., San Diego, Calif.). Western immunoblots were used to evaluate serum antibody responses to antigens from each of the probiotic bacteria (29) . The antigens were prepared from 48-h anaerobic cultures of each bacterial species grown in MRS broth. The entire volume of a 500-ml culture was centrifuged at 2,000 ϫ g for 15 min. The bacterial pellets were washed three times with an equal volume of PBS and centrifuged again. The final bacterial pellet was resuspended in 10 ml of PBS and passed through a French pressure cell (SLM/AMINCO, Urbana, Ill.) at 15,000 lb/in 2 to disrupt the bacteria. The disrupted bacteria were centrifuged at 2,000 ϫ g, and the protein content of the supernatant was determined by the bicinchoninic acid protein assay (Pierce Chemical Co., Rockford, Ill.) and used as the antigen for Western blot analyses and lymphocyte proliferation assays.
Antigen preparations (200 g) were applied to single-lane 4 to 20% polyacrylamide minigels and electrophoresed at 35 mA until the bromphenol blue tracking dye reached the end of the gels. The gels were electroblotted to nitrocellulose membranes, which were incubated in TBS-Tween buffer (0.01 M Tris, 0.15 M NaCl, 0.2% Tween 20 [polyoxyethylene sorbitan monolaurate; Sigma Chemical Co., St. Louis, Mo.])-5% powdered milk for 30 min to block nonspecific antibody binding sites. Pooled serum samples from probiotic-colonized mice were diluted 1:20 in TBS-Tween buffer-1% powdered milk and incubated in lanes on the blots maintained with a Miniblotter-16 (Immunetics, Cambridge, Mass.) for 2 h. The blots were washed with TBS-Tween buffer and incubated for 1 h with alkaline phosphatase-conjugated goat antiserum to mouse IgG, IgA, or IgM (Zymed) diluted 1:1,000. The nitrocellulose strips were washed and incubated with nitroblue tetrazolium-5-bromo-4-chloro-3-indolylphosphate toluidinium (NBT/ BCIP) substrate solution (Sigma) until bands appeared.
Lymphocyte proliferation assays were performed with the CellTiter Aqueous 96 assay kit (Promega Corp., Madison, Wis.). Splenic lymphocytes were prepared as previously described (29) . The spleen cells were pipetted into 96-well culture plates in 200 ml of RPMI 1640 medium (Sigma) with 5% fetal calf serum (BioWhittaker, Walkersville, Md.) at a concentration of 5 ϫ 10 5 cells/well. Each mitogen or antigen was added to three wells of spleen cells at the following optimized concentrations: 10 g of lipopolysaccharide (Sigma)/well, 0.5 g of concanavalin A (Sigma)/well, and 2 to 10 g of antigen preparation from each probiotic species. The plates were incubated in 5% CO 2 at 37°C for 56 h, 20 l of Promega MTS/PMS solution [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfonyl)-2H-tetrazolium and phenazine methosulfate] was added per well, and the plates were incubated for an additional 2 h. The absorbance at 490 nm was measured with an enzyme-linked immunosorbent assay plate reader (Dynatech Laboratories, Inc., Chantilly, Va.), and the absorbance of medium control wells was subtracted from values recorded for each mitogen or antigen. The average result from three wells per sample was used to determine the mean absorbance at 490 nm and standard error of the mean (SEM) for three mice per group.
Statistical analyses. Statistical analyses of the data were performed by a biostatistician (Dennis Heisey, Department of Surgery, University of Wisconsin Medical School, Madison) with SAS software (24) .
Kaplan-Meier survival curves were generated to assess differences in survival of bg/bg-nu/nu and bg/bg-nu/ϩ mice colonized with a probiotic bacterium. Differences between the curves were tested for significance with the log rank test. Two-way analysis of variance with the factors of treatment group and sex was used to assess the effects of probiotics on the growth of mice. Repeated-measures analysis of variance was used to test for differences in the numbers of probiotic bacteria in the gastrointestinal tracts and internal organs of bg/bg-nu/nu and bg/bg-nu/ϩ mice.
RESULTS
Gastrointestinal tract colonization by probiotics. One inoculation was sufficient to establish the probiotic bacteria in the alimentary tracts of both mouse strains. Weekly cultures of feces from gnotobiotic bg/bg-nu/nu and bg/bg-nu/ϩ mice demonstrated that both strains of mice were colonized with similar numbers of probiotic bacteria (in the range of 10 8 to 10 10 CFU/g) and that the mice remained colonized with pure cultures of the probiotics throughout the 12-week study (Table 1) . Neither mouse strain eliminated any of the four probiotic bacteria from their alimentary tracts. Also, newborn mice, born to probiotic-colonized mothers, had 10 6 to 10 7 CFU/g in their gastrointestinal tracts by 7 days after birth. At 12 days after birth, they were colonized with adult levels of 10 8 to 10 10 CFU/g. Quantitative assessments of viable bacteria in the contents of the stomach, small intestine, cecum, and colon from mice that had been sacrificed were carried out to determine if the probiotic species had different capacities to colonize specific portions of the gastrointestinal tract. Table 1 shows that all of the probiotics colonized the gastrointestinal tracts of bg/bgnu/nu and bg/bg-nu/ϩ mice with large numbers of viable bacteria. For all four probiotic bacteria, the cecum contained larger numbers of bacteria than the stomach, small intestine, or colon ( Table 1 ). The pHs of the stomach and intestinal contents from GF mice and probiotic-colonized mice were not significantly different. The stomach pH values were 5.1 Ϯ 0.1 and 5.1 Ϯ 0.7 in GF and probiotic-colonized mice, respectively.
Intestinal pH values (6.6 Ϯ 0.6 in the small intestines and 6.9 Ϯ 0.3 in the ceca) were similer for both GF and probiotic-colonized mice.
Gram stains of direct tissue impression slides were prepared to assess the incidence of probiotic bacterial adhesion to gastric epithelial cells. Adherence of L. acidophilus and B. animalis to stomach epithelial cells was observed in 86 and 82%, respectively, of gastric impression Gram stains from both bg/ bg-nu/nu and bg/bg-nu/ϩ mice. L. reuteri and L. casei GG were observed to be adherent to epithelial cells in only 2 and 5%, respectively, of impression smears from both bg/bg-nu/nu and bg/bg-nu/ϩ mice respectively (P Ͻ 0.05; 11 to 23 samples/ group). None of the four probiotic bacteria were more adherent to bg/bg-nu/nu gastric epithelial cells than to bg/bg-nu/ϩ cells.
Translocation (systemic dissemination) of probiotics. Probiotics differed in their capacities to disseminate from the gastrointestinal tract to internal organs. No significant translocation by L. reuteri was detected (Table 2) . Conversely, translocation to internal organs was detected in 50% and 55% of bg/bg-nu/nu mice colonized with L. acidophilus or B. animalis, respectively ( Table 2 ). The incidence of translocation in bg/bgnu/ϩ mice colonized with L. acidophilus or B. animalis was 30%. Translocation of L. casei GG was also observed in 27% of bg/bg-nu/nu and 26% of bg/bg-nu/ϩ mice. The numbers of probiotic bacteria cultured from the internal organs of the probiotic-colonized mice ranged from 3.3 log 10 CFU/g of homogenized tissues from B. animalis-colonized bg/bg-nu/ϩ mice to 6.5 log 10 CFU/g of homogenized tissues from L. acidophiluscolonized bg/bg-nu/nu mice ( Table 2 ). The number of L. acidophilus or B. animalis organisms present in internal organs of bg/bg-nu/nu mice was significantly greater than in the organs of the bg/bg-nu/ϩ mice. No difference was seen in the number of L. casei GG organisms in tissues from bg/bg-nu/nu and bg/bgnu/ϩ mice.
Histological evaluations of tissues from probiotic-colonized mice. Tissue sections were obtained from at least six mice colonized with each probiotic species for 4 to 12 weeks. The tissue sections were stained with hematoxylin and eosin and with a Gram stain. In agreement with the direct tissue impression data described above, Gram stains of gastric tissue sections from gnotobiotic mice showed that L. acidophilus and B. animalis (Fig. 1A) were more adherent to the keratinized epithelium than were L. reuteri and L. casei (Fig. 1B) . Probiotic bacteria were not observed on the secretory epithelium of the stomach.
Histological analysis also revealed abscesses in the stomachs and small intestines of some mice colonized with L. reuteri (29%), L. casei GG (29%), or B. animalis (11%). The abscesses were present in mucosal and submucosal regions of the tissues (Fig. 1C) . Histological examinations of tissues from 7-and 12-day-old L. casei GG-and B. animalis-colonized pups (four of each strain) did not show any evidence of pathologic changes in the gastrointestinal tract or internal organs.
Survival of probiotic-colonized mice. No morbidity or mortality was observed in adult bg/bg-nu/nu or bg/bg-nu/ϩ mice colonized from 4 to 12 weeks with L. acidophilus, L. reuteri, L. casei GG, or B. animalis (Table 3) .
Survival of newborn mice, born to mothers colonized with a probiotic species, was also recorded. All bg/bg-nu/ϩ and bg/bgnu/nu pups of L. acidophilus-or B. animalis-colonized mice survived through the 12-week study period. The bg/bg-nu/ϩ mice born to mothers colonized with L. casei GG all survived during the 12-week evaluation period; however, 36% of bg/bgnu/nu pups born to L. casei GG-colonized mothers died before 4 weeks of age (Table 3 ). All bg/bg-nu/ϩ pups born to L. reuteri-colonized mothers survived, but 21% of the bg/bg-nu/nu pups died.
Effects of colonization with probiotics on reproduction. The litter size averaged from 9 to 10 pups and consisted of roughly equal numbers of bg/bg-nu/nu and bg/bg-nu/ϩ mice and male and female mice. Colonization with probiotic bacteria did not appear to affect reproduction.
Effects of probiotics on adult body weights. Adult GF mice at least 8 weeks of age, when they had reached mature size, were monoassociated with a probiotic bacterium. The mice were removed from the gnotobiotic isolators at 4, 8, and 12 weeks after colonization with C. albicans and weighed. The body weights were compared to those of GF control mice of similar ages to establish whether monoassociation with probiotic bacteria affected their average adult body weights. We observed that adult male bg/bg-nu/nu and female bg/bg-nu/ϩ mice colonized for 4 to 12 weeks with L. acidophilus had body weights that were 60 and 76%, respectively, of the weights of their GF counterparts and that male bg/bg-nu/nu mice colonized with B. animalis were 87% of the size of the corresponding GF animals ( Table 4) . Female bg/bg-nu/nu and male bg/bgnu/ϩ mice colonized with L. acidophilus and female bg/bgnu/ϩ mice colonized with L. reuteri or B. animalis had significantly greater body weights than did the corresponding GF controls (Table 4) .
Effects of probiotics on growth of neonatal mice. Male bg/ bg-nu/nu pups colonized with B. animalis, female bg/bg-nu/nu pups colonized with L. acidophilus, and female bg/bg-nu/ϩ pups colonized with L. reuteri were significantly smaller than the GF controls at 8 weeks of age (Table 5 ). In contrast, male bg/bg-nu/nu pups colonized with L. reuteri had significantly greater body weights than did the isogenic GF controls (Table  5) .
Immune responses. Serum IgM and IgG were induced in bg/bg-nu/nu mice by L. casei GG and B. animalis but not by L. acidophilus or L. reuteri (Table 6 ). Production of IgM and IgG in bg/bg-nu/ϩ mice was induced by L. acidophilus, L. casei GG, and B. animalis but not by L. reuteri. None of the probiotic bacteria were able to induce a significant increase in IgA production in bg/bg-nu/nu mice, which is consistent with the lack of thymus-matured T cells in these mice. IgA production in serum was induced in bg/bg-nu/ϩ mice by L. casei GG and B. animalis (Table 6) .
Igs in sera from bg/bg-nu/ϩ mice colonized with L. casei GG or B. animalis not only showed strong specific reactivity with antigens prepared from the bacteria with which the mice were colonized but also had antibodies that cross-reacted with antigens prepared from the other probiotic bacteria (Fig. 2) . Conversely, L. reuteri colonization did not appear to induce a diversity of either specific or cross-reactive antibodies in the mice (Fig. 2) .
Lymphocytes from the spleens of GF and L. acidophilus, L. casei GG, and B. animalis-colonized bg/bg-nu/ϩ mice proliferated in response to the B-cell and T-cell mitogens lipopolysaccharide and concanavalin A, respectively, but not to antigens from the probiotic species that colonized the mice (data not shown).
DISCUSSION
The purpose of this study was to assess the pathogenesis of probiotic bacteria for congenitally immunodeficient mice. The probiotic bacteria used in this study were chosen because they were commercially available isolates used in probiotic products. The L. acidophilus, L. reuteri, and B. animalis strains are available as a blend, and the L. casei GG isolate has been extensively studied (11) (12) (13) . The beige nude mice have defects in phagocytic cells and NK cell activity and are without a functional thymus. Our gnotobiotic system showed that the four probiotic bacteria we studied colonized and persisted in very large numbers, in pure culture, in the alimentary tracts of both strains of gnotobiotic mice. In a recent review, McFarland (14) 100 (11) 100 (22) 100 (16) a Survival was significantly less than that of GF controls by log rank statistics (P Ͻ 0.05). and Elmer (13) suggested that a useful biotherapeutic agent must survive transit to an intestinal site, which favors its attachment and multiplication. Our data show that L. acidophilus, L. reuteri, L. casei GG, and B. animalis persisted in all sections of the murine alimentary tract, in pure culture, throughout the 12-week study. Persistent colonization by Lactobacillus spp. and Bifidobacterium spp. in humans has been described previously (8, 11, 20, 22) but usually with the caveat that the bacteria were adapted to a specific host (13) . Even though L. acidophilus, L. reuteri, and L. casei GG were of human origin, they apparently had no difficulty in colonizing the alimentary tracts of gnotobiotic mice. The consistent isolation of viable probiotic bacteria from the gnotobiotic mice demonstrates that the four species of probiotic bacteria were capable of colonizing the host's alimentary tract. These latter data suggest that competition with bacteria and/or a varied dietary composition would be major determinants of colonization and persistence of the probiotic bacteria in animals with a conventional microbial flora.
Probiotic bacterial species have occasionally been associated with infectious disease in humans. In one study, Bifidobacterium spp. and Lactobacillus spp. were isolated from abdominal and reproductive tract abscesses at a frequency of about 4% (15) . In another study, 8 of 3,317 blood cultures were positive for L. casei, none of which were related to L. casei GG (26) . Thus, the risk of infection by lactobacilli in the general human population appears to be low; however, little is known of the pathogenesis of lactobacilli in immunodeficient hosts. Our experiments with athymic bg/bg-nu/nu mice are among the first to evaluate the pathogenic potential of orally ingested probiotics for congenitally immunodeficient hosts.
That some probiotics can induce pathologic changes in an immunodeficient host was evident in our study because mucosal and submucosal abscesses were detected in the stomachs of some bg/bg-nu/nu mice colonized with L. reuteri, L. casei, or B.
animalis. Lacking complete NK cell activity, phagocytic cell functions, and T-cell-mediated immunity, bg/bg-nu/nu mice may be more dependent on polymorphonuclear leukocytes and macrophages for protection from intestinal microbes. Cell wall components of L. casei have been shown to induce inflammatory heart disease in mice, demonstrating that lactobacilli have the potential to induce inflammation (17) . Cell wall fragments from Eubacterium spp. and Bifidobacterium spp. can also induce arthritis in Lewis rats (10) . In our study, mice colonized with L. acidophilus, L. reuteri, L. casei GG, or B. animalis did not exhibit any ambulatory problems or other signs of arthritis. Translocation is a term given to the passage of microorganisms from the gut into the internal organs of the host (3). One of the beneficial effects attributed to probiotic bacteria is the inhibition of translocation by pathogenic microorganisms (2, 9) . Conversely, the probiotic bacteria may also be able to translocate in immunodeficient hosts. Translocation of L. acidophilus and L. casei GG in gnotobiotic mice has been previously reported (12) . In our experiments, some probiotics (L. acidophilus and B. animalis) translocated in 50% of the mice examined. The numbers of bacteria that disseminated to the If the probiotics are opportunistic pathogens, they should be able to cause some morbidity, mortality, or pathologic changes in the immunodeficient bg/bg-nu/nu mice. No adult bg/bg-nu/nu or bg/bg-nu/ϩ mice colonized with probiotic bacteria showed outward signs of illness, and none died during the course of these experiments. The probiotic bacteria neither retarded nor enhanced the growth of both male and female (athymic or euthymic) mice. Conversely, there was significant mortality in bg/bg-nu/nu pups, by 4 weeks of age, born to mothers colonized with L. reuteri or L. casei GG; however, no further mortality was evident between 4 and 12 weeks of age. Histological examinations of tissues from 7-and 12-day old L. casei GGcolonized pups (four of each strain) did not show any evidence of pathologic changes in the gastrointestinal tract or internal organs. Thus, the reason for the infant mortality in L. casei GG-colonized pups remains unknown. We have not come across any other reports of infant mortality by natural or experimental colonization with probiotic bacteria.
Numerous reports suggest that probiotic bacteria can cause immunomodulatory effects that lead to enhanced resistance to enteric pathogens (15, 18, 30) . A common immunomodulatory effect of probiotic bacteria is to increase antibody production (18, 30, 31) . Probiotic bacteria have been reported to protect mice from infections by gastrointestinal pathogens by increasing IgA production. For example, probiotic-enhanced resistance to Shigella sonnei (15) , Salmonella typhimurium, Escherichia coli (19) , and rotavirus (30) infections have all been associated with increased IgA production that was apparently induced by feeding probiotic microorganisms.
In our study, all four probiotic bacteria studied induced serum antibodies in euthymic bg/bg-nu/ϩ mice, and IgA production was induced by L. casei GG and B. animalis. Athymic bg/bg-nu/nu mice, colonized with a pure culture of the four probiotic species tested, failed to show any significant increases in serum IgA. Serum antibodies were produced by bg/bg-nu/ϩ mice colonized with L. acidophilus, L. casei GG, or B. animalis and cross-reacted with antigens from the other probiotic species used in these studies. The cross-reactivity of antibodies to probiotic bacteria suggests the presence of common epitopes on these probiotic bacteria.
There have not been many reports on the effects of probiotic bacteria on cell-mediated immunity. Cell wall extracts from B. infantis have been shown to increase experimental delayedtype hypersensitivity responses in mice (27) . Interestingly, in the present study we observed no increased proliferation of splenocytes (i.e., greater than the number of spleen cells from GF controls) from mice colonized with L. acidophilus, L. casei GG, or B. animalis upon incubation with antigens from the colonizing bacteria. The induction of cross-reactive antibodies but not lymphoproliferative responses suggests a T-cell-independent activation of immunity to the probiotic bacteria. The lack of a specific in vitro proliferative response suggests that these probiotic bacteria failed to induce specific cell-mediated immunity in bg/bg-nu/ϩ mice under these gnotobiotic conditions. In accord with the latter observations, others have also suggested that probiotic species do not induce cell-mediated immune responses in mice (28) .
In summary, we have shown that human isolates of L. acidophilus, L. reuteri, L. casei GG, and B. animalis can colonize the gastrointestinal tracts of immunodeficient mice. Colonization of bg/bg-nu/ϩ mice with L. acidophilus and with L. casei GG or B. animalis in either mouse strain was associated with increased production of antibodies in serum, but we detected no increased lymphocyte proliferation in response to specific probiotic antigens in vitro. Systemic dissemination and induction of mucosal inflammation were indications that the bacteria had infected the mice. Adult bg/bg-nu/nu and bg/bg-nu/ϩ mice survived colonization, but some infant mortality was associated with colonization by L. reuteri or L. casei GG. Thus, L. acidophilus and B. animalis appear to be innocuous probiotics in immunodeficient mice. Overall, probiotic bacteria are likely to be safe for immunocompetent and immunodeficient adults, but they should be tested for safety in immunodeficient neonates.
